Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Larry Couture | M | 67 |
Orbsen Therapeutics Ltd.
 Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
| Frank Barry | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
| Timothy O’Brien | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | 18 years |
| Robert Snukal | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
| Jack Kavanaugh | M | 76 |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | 9 years |
| Gerry Cuddy | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
| Stephen Elliman | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Coughlan | M | - |
Orbsen Therapeutics Ltd.
Orbsen Therapeutics Ltd. BiotechnologyHealth Technology Orbsen Therapeutics Ltd. operates as a regenerative medicine company. It engages in the development of therapies including Acute Respiratory Distress Syndrome, Diabetic Foot Ulcers, Diabetic Kidney Disease, Primary Sclerosing Cholangitis, and Sepsis. The company was founded in 2006 and is headquartered in Galway, Ireland. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Fahy
- Personal Network
